- Home
- BARK vs ADCT Comparison
BARK vs ADCT Comparison
Compare BARK & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- ADCT
- Stock Information
- Founded
- BARK 2011
- ADCT 2011
- Country
- BARK United States
- ADCT Switzerland
- Employees
- BARK N/A
- ADCT N/A
- Industry
- BARK Department/Specialty Retail Stores
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- ADCT Health Care
- Exchange
- BARK Nasdaq
- ADCT Nasdaq
- Market Cap
- BARK 244.9M
- ADCT 398.2M
- IPO Year
- BARK N/A
- ADCT 2020
- Fundamental
- Price
- BARK $0.83
- ADCT $3.24
- Analyst Decision
- BARK Strong Buy
- ADCT Strong Buy
- Analyst Count
- BARK 3
- ADCT 6
- Target Price
- BARK $2.50
- ADCT $7.80
- AVG Volume (30 Days)
- BARK 675.6K
- ADCT 545.2K
- Earning Date
- BARK 11-06-2025
- ADCT 11-06-2025
- Dividend Yield
- BARK N/A
- ADCT N/A
- EPS Growth
- BARK N/A
- ADCT N/A
- EPS
- BARK N/A
- ADCT N/A
- Revenue
- BARK $470,831,000.00
- ADCT $77,246,000.00
- Revenue This Year
- BARK N/A
- ADCT $13.10
- Revenue Next Year
- BARK $6.25
- ADCT $6.23
- P/E Ratio
- BARK N/A
- ADCT N/A
- Revenue Growth
- BARK N/A
- ADCT 15.73
- 52 Week Low
- BARK $0.77
- ADCT $1.05
- 52 Week High
- BARK $2.56
- ADCT $3.97
- Technical
- Relative Strength Index (RSI)
- BARK 43.88
- ADCT 51.93
- Support Level
- BARK $0.81
- ADCT $3.15
- Resistance Level
- BARK $0.91
- ADCT $3.38
- Average True Range (ATR)
- BARK 0.05
- ADCT 0.18
- MACD
- BARK -0.01
- ADCT -0.02
- Stochastic Oscillator
- BARK 13.88
- ADCT 38.53
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).